Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
30.43
+0.63 (2.11%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Immunocore Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 310.2 | 249.43 | 174.36 | 36.48 | 30.11 | Upgrade
|
| Revenue | 310.2 | 249.43 | 174.36 | 36.48 | 30.11 | Upgrade
|
| Revenue Growth (YoY) | 24.37% | 43.05% | 377.91% | 21.15% | 17.32% | Upgrade
|
| Cost of Revenue | 10.5 | 7.5 | 6.4 | 100.25 | 74.81 | Upgrade
|
| Gross Profit | 299.7 | 241.92 | 167.96 | -63.76 | -44.7 | Upgrade
|
| Selling, General & Admin | 155.78 | 144.5 | 123.06 | 110.82 | 45.74 | Upgrade
|
| Research & Development | 214.38 | 157.08 | 96.61 | - | - | Upgrade
|
| Other Operating Expenses | -18.05 | 0.9 | -0.01 | 0.07 | -1.61 | Upgrade
|
| Operating Expenses | 352.11 | 302.47 | 219.66 | 110.9 | 44.13 | Upgrade
|
| Operating Income | -52.41 | -60.55 | -51.7 | -174.66 | -88.83 | Upgrade
|
| Interest Expense | -18.84 | -5.15 | -5.41 | -5.57 | -3.11 | Upgrade
|
| Interest & Investment Income | 25.62 | 17.99 | 3.76 | 0.07 | 0.71 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.45 | -13.18 | 14.16 | 0.29 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 1.24 | Upgrade
|
| EBT Excluding Unusual Items | -49.08 | -60.89 | -39.2 | -179.88 | -90 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -1.06 | Upgrade
|
| Other Unusual Items | -3.85 | - | -1.69 | - | 3.7 | Upgrade
|
| Pretax Income | -52.94 | -60.89 | -40.88 | -179.88 | -87.36 | Upgrade
|
| Income Tax Expense | -1.85 | -5.6 | 11.66 | 0.15 | -13.27 | Upgrade
|
| Net Income | -51.09 | -55.29 | -52.54 | -180.03 | -74.09 | Upgrade
|
| Net Income to Common | -51.09 | -55.29 | -52.54 | -180.03 | -74.09 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 49 | 46 | 42 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 49 | 46 | 42 | 27 | Upgrade
|
| Shares Change (YoY) | 2.25% | 6.94% | 7.59% | 60.19% | 18.95% | Upgrade
|
| EPS (Basic) | -1.02 | -1.13 | -1.15 | -4.24 | -2.79 | Upgrade
|
| EPS (Diluted) | -1.02 | -1.13 | -1.15 | -4.24 | -2.79 | Upgrade
|
| Free Cash Flow | 20.89 | -2.49 | -51.41 | -144.49 | -64.32 | Upgrade
|
| Free Cash Flow Per Share | 0.42 | -0.05 | -1.13 | -3.40 | -2.42 | Upgrade
|
| Gross Margin | 96.61% | 96.99% | 96.33% | -174.77% | -148.42% | Upgrade
|
| Operating Margin | -16.89% | -24.27% | -29.65% | -478.73% | -294.98% | Upgrade
|
| Profit Margin | -16.47% | -22.17% | -30.14% | -493.45% | -246.04% | Upgrade
|
| Free Cash Flow Margin | 6.73% | -1.00% | -29.49% | -396.04% | -213.60% | Upgrade
|
| EBITDA | -48.21 | -56.46 | -46.37 | -167.07 | -82.38 | Upgrade
|
| EBITDA Margin | -15.54% | -22.63% | -26.59% | - | -273.57% | Upgrade
|
| D&A For EBITDA | 4.2 | 4.09 | 5.34 | 7.59 | 6.45 | Upgrade
|
| EBIT | -52.41 | -60.55 | -51.7 | -174.66 | -88.83 | Upgrade
|
| EBIT Margin | -16.89% | -24.27% | -29.65% | - | -294.98% | Upgrade
|
| Revenue as Reported | 310.2 | 249.43 | 174.36 | 36.48 | 30.11 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.